AI assistant
Sending…
CONMED Corp — Director's Dealing 2013
Sep 13, 2013
31971_dirs_2013-09-13_fa7ecd96-b914-4c01-9605-275e6bf68b44.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-09-11
Reporting Person: ABRAHAM WILLIAM (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-09-11 | Common Stock | M | 2577 | $25.03 | Acquired | 21659 | Direct |
| 2013-09-11 | Common Stock | M | 7423 | $25.03 | Acquired | 29082 | Direct |
| 2013-09-11 | Common Stock | S | 7423 | $33.4809 | Disposed | 21659 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-09-11 | Options To Purchase Common Stock | $25.03 | M | 2577 | Disposed | 2014-05-18 | Common Stock (2577) | Direct |
| 2013-09-11 | Options To Purchase Common Stock | $25.03 | M | 7423 | Disposed | 2014-05-18 | Common Stock (7423) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.45 to $33.52. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
F2: 5 year vesting schedule, 20% vest each year starting 5/18/2005
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7